<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>West Asia Organization for Cancer Prevention (WAOCP), APOCP's West Asia Chapter.</PublisherName>
				<JournalTitle>Asian Pacific Journal of Cancer Prevention</JournalTitle>
				<Issn>1513-7368</Issn>
				<Volume>12</Volume>
				<Issue>11</Issue>
				<PubDate PubStatus="epublish">
					<Year>2011</Year>
					<Month>11</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Implications of Greater Short-term PSA Recurrence with Laparoscopic as Compared to Retropubic Radical Prostatectomy for Japanese Clinically localized Prostate Carcinomas</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>2959</FirstPage>
			<LastPage>2961</LastPage>
			<ELocationID EIdType="pii">25994</ELocationID>
			
			
			<Language>EN</Language>
<AuthorList>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>1970</Year>
					<Month>01</Month>
					<Day>01</Day>
				</PubDate>
			</History>
		<Abstract>Purpose: There is ongoing discussion as to the necessity for certain surgical procedures being limited to high through-put institutions. To cast light on this question regarding use of open as compared to laparoscopic radical prostatectomy (LRP) the present study was conducted focusing on biochemical (PSA) recurrence-free survival of Japanese patients with clinically localized prostate carcinomas. Materials and &lt;br/&gt;&lt;b&gt;Methods&lt;/b&gt;: From April 2004 to December 2010 we identified 579 patients undergoing LRP (n=245) and retropubic radical prostatectomy (RRP) (n=334) who did not undergo immediate adjuvant therapy (radiation and/or hormonal) and whose PSA levels were lower than 25 ng/ml. Preoperative prostate specific antigen (PSA) level, clinical stage, biopsy Gleason score and pathological features were assessed and Kaplan-Meier estimates of biochemical recurrence (BCR)-free survival were compared. A Cox regression model analysis was performed to determine predictors of biochemical recurrence. &lt;br/&gt;&lt;b&gt;Results&lt;/b&gt;: Median follow up was 35 months(2- 115). On univariate analysis the LRP group had a slightly lower pathological T stage (p&lt;0.001), higher biopsy Gleason score (p&lt;0.001), but much more organ confined disease (p=0.001) than the RRP group. BCR-free survival did not significantly differ between LRP and RRP groups with preoperative PSA &lt;6, clinical stage T1c,T2a, pathological stage T3 or more, biopsy Gleason score of 8 or more, pathological Gleason score of 6 or less and 8 or more, extra-capsular extension and negative surgical margin. The 3-year BCR-free survival rates were 91.0%(RRP) and 82.2%(LRP) (p&lt;0.001). &lt;br/&gt;&lt;b&gt;Conclusion&lt;/b&gt;: We conclude that in general LRP may be associated with a less positive outcome than BCR for resection of low risk prostate cancers. Therefore indications for LRP should be very carefully monitored.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Laparoscopic retropubic radical prostatectomy</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">PSA recurrence- clinically localized prostate carcinomas</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://journal.waocp.org/article_25994_9017c59d814f5225fc7f7ec62b70b991.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
